CLINONE, INC.

Profile

Company Names

CLINONE, INC.

Addresses

117 KENDRICK ST, SUITE 300, NEEDHAM, MA 02494

1515 WYNKOOP, SUITE 360, DENVER, CO 80202

Phone Numbers

800-343-6920
1-800-343-6690

 

Entity Type:

CORPORATION

Industry:

OTHER

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$14,175,927.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-04-03 
$10,505,178.00 
$12,377,908.00 
$1,872,730.00 
Equity 
1
2018-01-16 
$3,670,749.00 
$4,345,780.00 
$675,031.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
BOHACS 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLINONE, INC.
MICHAEL 
 
CARRUTHERS 
EXECUTIVE OFFICER
CLINONE, INC.
BOB 
 
CONWAY 
DIRECTOR
CLINONE, INC.
ROBERT 
 
CONWAY 
DIRECTOR
CLINONE, INC.   |  ALPINE IMMUNE SCIENCES, INC.
GINO 
 
DISCIULLO 
DIRECTOR
GREAT LAKES PHARMACEUTICALS, INC.   |  CLINONE, INC.   |  MIRABILIS MEDICA, INC.   |  NEURAPTIVE THERAPEUTICS, INC.
ROBERT 
 
HALE 
DIRECTOR
CLINONE, INC.   |  HONEY BADGER ACQUISITIONS 1 LLC   |  FREDERICKSBURG GLUCKSBRINGER LLC   |  SMARTBIZ BANCSHARES, INC.
STEVE 
 
LINDSETH 
DIRECTOR
RXREVU, INC.   |  STATRAD HOLDCO, LLC   |  CLINONE, INC.   |  HUMMINGBIRD HEALTHCARE, INC.
GAIL 
 
PIERCE 
EXECUTIVE OFFICER
LAGRANGE SYSTEMS, INC.   |  CLINONE, INC.
ERIC 
 
SCHRAUFNAGEL 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLINONE, INC.
ANDREA 
 
VALENTE 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
CLINONE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-04-13
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2023-04-03 
2018-12-14
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-16 
2018-01-29
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#